Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00159666 · ClinicalTrials.gov registry record · Phase 4
Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia
A Phase 4 study of Post Herpetic Neuralgia, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- Completed
- Registry status
- Phase 4
- Development phase
- 255
- Enrollment target
- 20
- Study locations
NCT00159666: Completed Phase 4 study of Post Herpetic Neuralgia, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
NCT00159666 is a Phase 4 study of Post Herpetic Neuralgia that has completed, run by Pfizer's Upjohn has merged with Mylan to form Viatris. The registered enrollment target is 255 participants, above the 102-participant average among 4 other Post Herpetic Neuralgia trials with a reported enrollment target (150% higher). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00159666, a Phase 4 study of Post Herpetic Neuralgia, has completed, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 255 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to measure how rapidly pregabalin treatment can relieve pain in patients with post-herpetic neuralgia
Conditions Studied
Interventions
- DRUG pregabalin
Study Locations (20)
Other
- Pfizer Investigational Site - Berlin
- Pfizer Investigational Site - Bochum
- Pfizer Investigational Site - Düsseldorf
- Pfizer Investigational Site - Frankfurt
- Pfizer Investigational Site - Göppingen
- Pfizer Investigational Site - Hamburg
Arizona
- Pfizer Investigational Site - Phoenix
Arkansas
- Pfizer Investigational Site - Little Rock
California
- Pfizer Investigational Site - Duarte
Colorado
- Pfizer Investigational Site - Denver
Florida
- Pfizer Investigational Site - Palm Beach Gardens
Illinois
- Pfizer Investigational Site - Oak Brook
Mississippi
- Pfizer Investigational Site - Flowood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-06 |
| Phase | Phase 4 |
What the finished NCT00159666 record still lists
NCT00159666 is an interventional study that assigns participants to a tested intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap, above the 102-participant average among 4 other Post Herpetic Neuralgia trials with a reported enrollment target (150% higher).
The record links to 1 condition, with Post Herpetic Neuralgia appearing as the primary indexed condition, and to 1 intervention - of which pregabalin is the first listed.
NCT00159666 names 20 study sites across 15 states, led by Other, Arizona, Arkansas.
Frequently Asked Questions
What is clinical trial NCT00159666 about?
NCT00159666 is a clinical study titled "Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia". The purpose of this study is to measure how rapidly pregabalin treatment can relieve pain in patients with post-herpetic neuralgia
What is the current status of trial NCT00159666?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 255 participants. The study started on 2004-10. Estimated completion is 2006-06.
What conditions does trial NCT00159666 study?
This clinical trial studies the following conditions: Post Herpetic Neuralgia.
What interventions are being tested in trial NCT00159666?
The interventions under investigation include: pregabalin (DRUG).
Who is sponsoring clinical trial NCT00159666?
This trial is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00159666 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Herpetic Neuralgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
COMPLETED · Phase 4
-
Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain
RECRUITING · NA
-
Transcranial Magnetic Stimulation for Chronic Neuropathic Pain
ACTIVE NOT RECRUITING · NA
-
A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia